Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |  Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 440Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

  Article Access Statistics

Year : 2018 | Volume:  9 | Issue Number:  4 | Page:  187-188

LETTER TO EDITOR

From “Glivec®” to “Prevnar 13®”: How strong is the Indian drug patenting system?
Raj Gerard Marshall

Number of times this article was viewed 404
Number of times this article has been printed  from the site 12
Number of times this article was emailed to others 0
Remarks given by readers [ Read ] 0

 

  Feedback 
  Subscribe 
 Back To Article

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal